









Markets
/
Stocks
/
nasdaq-holx
/

Hologic Inc

HOLX

63.800USD

-0.650-1.01%

Close 09/15, 16:00（ET）Quotes delayed by 15 min

14.18BMarket Cap

25.45P/E TTM



Hologic Inc

63.800

-0.650-1.01%

Overview Company Financials Analysis

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

TradingKey Stock Score

Currency: USD Updated：2025-09-15

Key Insights

The company's fundamentals are relatively very healthy. Its valuation is considered undervalued,and institutional recognition is very high. Over the past 30 days, multiple analysts have rated the company as a Buy. Despite an average stock market performance, the company shows strong fundamentals and technicals. The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Industry Ranking

46 / 207

Overall Ranking

163 / 4724

Industry

Healthcare Equipment & Supplies

Support & Resistance

No Data

Score Analysis

Current score

Previous score

Analyst Rating

Based on 22 analysts

Buy

Current Rating

73.008

Target Price

+13.28%

Upside Space

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Company Highlights

StrengthsRisks

Hologic, Inc. is a medical technology company primarily focused on improving women's health and well-being through early detection and treatment. The Company is a developer, manufacturer and supplier of diagnostics products, medical imaging systems, and surgical products. Its segments include Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. The Diagnostics segment offers a range of diagnostic products, which are used primarily to aid in the screening and diagnosis of human diseases. The Breast Health segment offers a broad portfolio of solutions for breast imaging, biopsy, breast surgery and pathology. The GYN Surgical segment's products include MyoSure hysteroscopic tissue removal system, NovaSure endometrial ablation system, Acessa ProVu laparoscopic radiofrequency ablation system, as well as CoolSeal vessel sealing portfolio and JustRight surgical stapler. The Skeletal Health segment's products include the Horizon DXA and the Fluoroscan Insight FD mini C-arm.

Fairly Valued

The company’s latest PE is 26.21, at a medium 3-year percentile range.

Institutional Selling

The latest institutional holdings are 230.47M shares, decreasing 5.37% quarter-over-quarter.

Held by The Vanguard

Star Investor The Vanguard holds 26.70M shares of this stock.

Financial Health

Currency: USD Updated：2025-09-15

The company's current financial score is 6.36, which is lower than the Healthcare Equipment & Supplies industry's average of 7.15. Its financial status is robust, and its operating efficiency is average. Its latest quarterly revenue reached 1.01B, representing a year-over-year decrease of 1.23%, while its net profit experienced a year-over-year decrease of 110.24%.

Score

Industry at a Glance

Previous score

6.36

Change

2.2



Financials

10.00

Key Metrics

Cash and cash equivalents

Total assets

Total liabilities

Free cash flow

No Data



Quality of Earnings

8.27

Key Metrics

Total revenue

Operating profit

Total assets

SG&A

No Data



Operational Efficiency

8.85

Key Metrics

Cash flow from operating activities

Income after tax

No Data



Growth Potential

8.33

Key Metrics

Cash flow from operating activities

Total revenue

No Data



Shareholder Returns

7.37

Key Metrics

Free cash flow

No Data

Company Valuation

Currency: USD Updated：2025-09-15

The company’s current valuation score is 1.80, which is lower than the Healthcare Equipment & Supplies industry's average of 2.15. Its current P/E ratio is 27.42, which is -1.39% below the recent high of 27.04 and 10.58% above the recent low of 24.52.

Score

Industry at a Glance

Previous score

1.80

Change

Valuation Dimensions

P/E

P/B

P/S

P/CF

Industry Ranking 46/207

No Data

Earnings Forecast

Currency: USD Updated：2025-09-15

The company’s current earnings forecast score is 6.82, which is lower than the Healthcare Equipment & Supplies industry's average of 7.66. The average price target for Hologic Inc is 72.00, with a high of 87.00 and a low of 65.00.

Score

Industry at a Glance

Previous score

7.09

Change

Support & Resistance

No Data

Analyst Rating

Based on 22 analysts

Buy

Current Rating

73.008

Target Price

+13.28%

Upside Space

Strong Buy

Buy

Hold

Sell

Strong Sell

Peer Comparison

Total

Median

Average

Company name

Ratings

Analysts

Hologic Inc

HOLX

Boston Scientific Corp

BSX

Edwards Lifesciences Corp

Intuitive Surgical Inc

ISRG

Veeva Systems Inc

VEEV

Thermo Fisher Scientific Inc

TMO

...

Financial Forecasting

EPS

Revenue

Net Profit

EBIT

No Data

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Price Momentum

Currency: USD Updated：2025-09-15

The company’s current price momentum score is 6.82, which is lower than the Healthcare Equipment & Supplies industry's average of 7.47. Sideways: Currently, the stock price is trading between the resistance level at 68.89 and the support level at 64.81, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score

6.24

Change

-0.03

Support & Resistance

No Data

Indicators



The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

Indicators

Sell(4)

Neutral(1)

Buy(0)

Indicators

Value

Direction

MACD(12,26,9)

-0.725

Sell

RSI(14)

35.634

Neutral

STOCH(KDJ)(9,3,3)

12.520

Sell

ATR(14)

1.114

High Vlolatility

CCI(14)

-249.227

Oversold

Williams %R

98.684

Oversold

TRIX(12,20)

-0.083

Sell

StochRSI(14)

0.000

Sell

Moving Average

Sell(5)

Neutral(0)

Buy(1)

Indicators

Value

Direction

MA5

65.371

Sell

MA10

65.939

Sell

MA20

66.645

Sell

MA50

66.361

Sell

MA100

63.453

Buy

MA200

65.389

Sell

Institutional Confidence

Currency: USD Updated：2025-09-15

The company’s current institutional recognition score is 10.00, which is higher than the Healthcare Equipment & Supplies industry's average of 7.19. The latest institutional shareholding proportion is 103.62%, representing a quarter-over-quarter decrease of 0.31%. The largest institutional shareholder is The Vanguard, holding a total of 26.70M shares, representing 12.00% of shares outstanding, with 1.68% increase in holdings.

Score

Industry at a Glance

Previous score

10.00

Change

Institutional Shareholding

No Data

Shareholder Activity

Name

Shares Held

Chg %

The Vanguard Group, Inc.

Star Investors

26.72M

-0.28%

T. Rowe Price Investment Management, Inc.

17.69M

-1.40%

BlackRock Institutional Trust Company, N.A.

13.46M

-1.38%

Manulife Investment Management (North America) Limited

2.80M

+17.12%

State Street Global Advisors (US)

10.11M

-2.28%

Geode Capital Management, L.L.C.

5.73M

-0.02%

Victory Capital Management Inc.

6.61M

+34.41%

Black Creek Investment Management, Inc.

3.20M

+37.70%

Invesco Capital Management LLC

Star Investors

4.37M

+19.63%

Risk Assessment

Currency: USD Updated：2025-09-15

The company's beta value is 0.57. This indicates that the stock tends to underperform the index during upward trending markets but experiences smaller declines during downward trending markets.